Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huoxue Bushen Anshen prescription for heart failure after acute myocardial infarction
ChiCTR2300074072Phase 3Not yet recruiting
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Jul 2023
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) comparing Huoxue Bushen Anshen prescription arm with Placebo arm (2 arms). Primary endpoints: Left ventricular end-systolic volume, Left ventricular end-diastolic volume and 1 more. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
Huoxue Bushen Anshen prescription
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ChiCTR2300074072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074072.